Entity Common Stock, Shares Outstanding of ALPINE IMMUNE SCIENCES, INC. from 31 Jul 2015 to 09 Apr 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ALPINE IMMUNE SCIENCES, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2015 to 09 Apr 2024.
  • ALPINE IMMUNE SCIENCES, INC. Entity Common Stock, Shares Outstanding for the quarter ending 09 Apr 2024 was 65,560,484, a 37% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ALPINE IMMUNE SCIENCES, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 65,560,484 +17,803,577 +37% 09 Apr 2024 10-K/A 26 Apr 2024 2023 FY
Q3 2023 58,097,961 +12,183,528 +27% 09 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 49,201,547 +18,800,868 +62% 04 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 47,756,907 +17,462,473 +58% 14 Mar 2023 10-K 23 Mar 2023 2022 FY
Q3 2022 45,914,433 +16,694,257 +57% 08 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 30,400,679 +6,485,800 +27% 05 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 30,294,434 +6,412,296 +27% 07 Mar 2022 10-K 17 Mar 2022 2021 FY
Q3 2021 29,220,176 +5,416,993 +23% 28 Oct 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 23,914,879 +130,029 +0.55% 30 Jul 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 23,882,138 +5,294,246 +28% 10 Mar 2021 10-K 18 Mar 2021 2020 FY
Q3 2020 23,803,183 +5,215,415 +28% 05 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 23,784,850 +5,197,206 +28% 03 Aug 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 18,587,892 +26,863 +0.14% 29 Feb 2020 10-K 30 Mar 2020 2019 FY
Q3 2019 18,587,768 +4,735,304 +34% 01 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 18,587,644 +4,736,882 +34% 08 Aug 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 18,561,029 +4,714,945 +34% 06 Mar 2019 10-K 18 Mar 2019 2018 FY
Q3 2018 13,852,464 -29,181 -0.21% 01 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 13,850,762 -1,805,489 -12% 06 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 13,846,084 -1,810,167 -12% 20 Mar 2018 10-K 28 Mar 2018 2017 FY
Q3 2017 13,881,645 -1,661,824 -11% 08 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 15,656,251 +153,102 +0.99% 21 Jul 2017 10-Q 21 Jul 2017 2017 Q2
Q1 2017 15,656,251 +194,221 +1.3% 30 Apr 2017 10-Q 02 May 2017 2017 Q1
Q4 2016 15,656,251 31 Jan 2017 10-K 13 Feb 2017 2016 FY
Q3 2016 15,543,469 +91,648 +0.59% 31 Oct 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 15,503,149 +51,328 +0.33% 31 Jul 2016 10-Q 02 Aug 2016 2016 Q2
Q1 2016 15,462,030 30 Apr 2016 10-Q 03 May 2016 2016 Q1
Q3 2015 15,451,821 31 Oct 2015 10-Q 03 Nov 2015 2015 Q3
Q2 2015 15,451,821 31 Jul 2015 10-Q 04 Aug 2015 2015 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.